Veru Inc.

NASDAQ:VERU

Biotechnology

Healthcare
$3.16 +4.33%

+$0.13 today

Market cap
$50.72M
Beta
-1.13
P/E (TTM)
-4.8
EPS (TTM)
-$0.65
52W Low $2.05High $7.33

Volume 0.34M

Average 1.82M

VERU Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

Veru Inc.NASDAQ: VERU

Other Stockholders Equity · Q2 FY2026 · quarter ended Mar 2026

Other stockholders equity remains negative

Q2 FY2026 other stockholders equity was $0, compared with $0 a year earlier.

Context

  • Other stockholders equity amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Other stockholders equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearSep 2025
$0— YoY
Year agoMar 2025
$0— since
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Other Stockholders Equity vs competitors

How VERU compares with its peers on the latest reported figures

  • VERU's Mar 2026 other stockholders equity of $0 is the highest of the 7 companies compared; the peer median is $0.
  • Other stockholders equity amounts to 0.0% of total assets for VERU, versus a peer median of 0.0%.
VERU Competitors Peer median
Other Stockholders Equity for VERU and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
VERUVeru Inc.Mar 2026$0 ——0.0%
MAIAMAIA Biotechnology, Inc.Mar 2026$0 ——0.0%
PYPDPolyPid Ltd.Mar 2026$0 ——0.0%
ANVSAnnovis Bio, Inc.Mar 2026$0 +100.0%—0.0%
RNXTRenovoRx, Inc.Mar 2026$0 ——0.0%
DYAIDyadic International, Inc.Mar 2026$0 -100.0%+0.0%0.0%
CELUCelularity Inc.Dec 2025$0 ——0.0%
Peer median (excluding VERU) $0+0.0%+0.0%0.0%

Competitors are the stored peer set for VERU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents122.36M80.19M9.63M24.92M15.79M
Short-term Investments00002.53M
Net Receivables13.79M3.55M4.51M3.96M0
Inventory5.57M8.62M6.7M4.14M0
Other Current Assets850.89K1.96M1.1M1.78M595.25K
Total Current Assets151.75M104M22.93M35.22M18.92M
Property, Plant & Equipment (Net)1.56M5.97M5.99M4.85M3.11M
Goodwill6.88M6.88M6.88M6.88M6.88M
Intangible Assets4.05M3.98M5.95K00
Long-term Investments(1.56M)0000
Tax Assets13.02M12.97M12.71M12.34M0
Other Non-current Assets2.44M1.56M1.51M1.13M930.85K
Total Non-current Assets26.39M31.36M27.09M25.2M10.92M
Total Assets178.15M135.36M50.02M60.42M29.84M
Account Payables3.41M22M12.93M3.04M3.12M
Short-term Debt3.24M1.17M864.62K1.03M0
Tax Payables00000
Deferred Revenue132K0105K400K0
Other Current Liabilities05.99M100K03.51M
Total Current Liabilities15.77M38.71M17.81M11.87M7.79M
Long-term Debt9.4M9.66M8.87M8.85M0
Deferred Tax Liabilities63.43K81.07K451.16K00
Deferred Revenue (Non-current)00(451.16K)00
Other Non-current Liabilities14.99K18.58K29.95K4.46M1.36M
Total Non-current Liabilities10.09M13.85M12.53M16.23M3.72M
Total Liabilities25.85M52.56M30.34M28.1M11.5M
Common Stock821.54K826.93K939.66K1.49M148.69K
Retained Earnings(81.8M)(163.62M)(256.77M)(294.57M)(317.3M)
Accumulated OCI(581.52K)(581.52K)(581.52K)(581.52K)0
Other Stockholders Equity00000
Minority Interest00000
Total Equity152.29M82.8M19.68M32.32M18.33M
Total Debt13.74M15.88M14.41M13.86M3.12M
Net Debt(108.61M)(64.31M)4.78M(11.05M)(12.68M)

Veru Inc.

NASDAQ:VERU

Intrinsic Alpha fair value

Locked

Current Price

$3.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.